Oxidative stress in insulin-resistant conditions: cardiovascular implications
Craig S Stump1, Suzanne E Clark, James R Sowers
1Department of Internal Medicine-Endocrinology, Harry S. Truman VA Medical Center, University of Missouri, Columbia, Missouri 65212, USA. stumpc@health.missouri.edu
Insights
Diabetic cardiovascular disease (CVD) risk is high due to complex factors beyond high blood sugar. New strategies targeting oxidative stress and insulin resistance are needed for better CVD outcomes in diabetes patients.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Syndrome
Background:
- Diabetes mellitus significantly increases cardiovascular disease (CVD) risk, being a leading cause of mortality in diabetic patients.
- Diabetes involves complex pathologies including hypertension, dyslipidemia, endothelial dysfunction, and chronic inflammation, contributing to CVD.
- Oxidative stress plays a critical role in the pathogenesis of diabetic CVD, impacting hypertension, renal disease, and stroke.
Purpose of the Study:
- To explore the multifaceted pathophysiology of cardiovascular disease in diabetes mellitus.
- To highlight the contribution of factors beyond hyperglycemia, such as oxidative stress and inflammation, to diabetic CVD.
- To identify potential targets for novel prevention strategies for CVD in diabetic populations.
Main Methods:
- Review of existing literature on the pathophysiology of diabetes and its association with cardiovascular disease.
- Analysis of the role of oxidative stress, inflammation, and the renin-angiotensin-aldosterone system in diabetic CVD.
- Examination of the impact of hypertension and dyslipidemia on CVD risk in diabetes.
Main Results:
- Cardiovascular disease risk is elevated over 3-fold in diabetes patients.
- Hypertension is a primary contributor to CVD in diabetes, emphasizing the need for blood pressure control.
- Oxidative stress and renin-angiotensin-aldosterone system activation contribute to endothelial dysfunction, inflammation, and insulin resistance in diabetic CVD.
Conclusions:
- Effective prevention of CVD in diabetes requires addressing complex pathophysiologic factors including oxidative stress and inflammation.
- Further research into antioxidant and insulin-sensitizing agents is crucial for improving CVD outcomes in patients with diabetes.
- Integrated management strategies targeting multiple risk factors are essential for mitigating CVD in the diabetic population.
Abstract:
The risk of cardiovascular disease (CVD) in patients with diabetes mellitus is increased more than 3-fold and is the major cause of mortality and morbidity in diabetic patients. Historically, diabetes has been considered an inadequate insulin response leading to elevated plasma glucose levels with morbidities attributable to hyperglycemia. However, diabetes represents a complex pathology that often includes hypertension, dyslipidemia, endothelial dysfunction, microalbuminuria, platelet disaggregation, abnormal fibrinolysis, and chronic inflammation. Furthermore, oxidative stress has been shown to contribute to the pathology of diabetic CVD, having implications in the development of hypertension, renal disease, and stroke. Hypertension is a common feature of diabetes and is the primary contributor to CVD, which highlights the importance of blood pressure control (<130/80 mm Hg). Recent investigations have also implicated the renin-angiotensin-aldosterone system in promoting oxidative stress-induced endothelial dysfunction, inflammation, and insulin resistance. These pathophysiologic considerations will be important in developing prevention strategies for CVD in diabetes. Further research is needed to identify antioxidant and insulin-sensitizing agents that will improve CVD outcomes in patients with diabetes.
More Related Videos
14:10A Microfluidic System for Modeling Endothelial Dysfunction under Combined Physiological Pulsatile Shear Stress and Oscillatory Hyperglycemia
Published on: May 12, 2026
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Related Concept Videos
Type II Diabetes II: Pathophysiology
Coronary Artery Disease I: Introduction
Type II Diabetes I: Introduction
Psychoneuroimmunology: Diabetes and Cancer
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease II: Pathophysiology
